# EndoClot Adhesive ECA2302

> Active: European Union and United States. Medical device record on deviCERTS, compiled from public registries.

- Canonical page: <https://devicerts.com/devices/endoclot-r-eca2302>
- Manufacturer: [EndoClot Plus Co., Ltd.](https://devicerts.com/manufacturers/endoclot-plus-co-ltd) (China)
- Name in the registry: EndoClot®
- Device class: Class IIa (EU MDD)
- EMDN: M040504 INORGANIC HAEMOSTATIC DEVICES

## Overview

*AI-generated summary, 2026-10-01. Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data is the record.*

The EndoClot Adhesive ECA2302 is a sterile, single-use hemostatic adhesive classified under nomenclature code M040504. Designed as a polysaccharide-based adhesive, it is intended for topical application to control bleeding in the gastrointestinal tract by forming a cohesive seal at the wound site. Its formulation is engineered to promote rapid clotting and tissue adhesion, reducing the risk of post-procedural hemorrhage during endoscopic interventions.

Supplied as a ready-to-use adhesive, the EndoClot ECA2302 is non-reusable and non-implantable, with no active components. It is packaged in a sterile, single-use format and requires no reprocessing. The device adheres to FDA 510(k) and MDD regulatory standards, ensuring compliance with medical device legislation. Storage conditions are not specified but must align with sterility requirements to maintain efficacy until use.

## Registrations and authorizations

- **EUDAMED** · CE/MDD · European Union · Basic UDI-DI B-46972011720135 · registered 2026-02-27 · status: Active
- **510(k)** · FDA 510(k) · United States · K190677 · issued 2021-01-29 · status: Active
- **510(k)** · FDA 510(k) · United States · K191254 · issued 2020-01-30 · status: Active
- **510(k)** · FDA 510(k) · United States · K162197 · issued 2017-01-18 · status: Active

## Recalls

No recall on record.

## Identity

- Model / reference: ECA2302 [EUDAMED]

## Identifiers

- Primary DI / UDI-DI: 46972011720135 [EUDAMED]; 56972011720132 [EUDAMED]; 36972011720138 [EUDAMED]; 16972011720134 [EUDAMED]; 26972011720131 [EUDAMED]
- Basic UDI-DI: B-46972011720135 [EUDAMED]; B-56972011720132 [EUDAMED]; B-36972011720138 [EUDAMED]; B-16972011720134 [EUDAMED]; B-26972011720131 [EUDAMED]
- EMDN code: M040504 [EUDAMED]

## Classification

- Device class: Class IIa [EUDAMED]
- EU registration type: Legacy device (under a directive) [EUDAMED]
- EU market of registration: Italy [EUDAMED]

## Properties

- Supplied sterile: Yes [EUDAMED]
- Sterilise before use: No [EUDAMED]
- Implantable: No [EUDAMED]
- Reusable: No [EUDAMED]
- Contains latex: No [EUDAMED]
- Reprocessed single-use device: No [EUDAMED]
- Incorporates a substance derived from human blood or plasma: No [EUDAMED]
- Contains human tissues or cells: No [EUDAMED]
- Contains animal tissues or cells: No [EUDAMED]
- Administering medicine: No [EUDAMED]
- Measuring function: No [EUDAMED]
- Incorporates a medicinal substance: No [EUDAMED]

## Source and citation

- Cite as: EndoClot Adhesive ECA2302, EndoClot Plus Co., Ltd. deviCERTS medical device catalogue. https://devicerts.com/devices/endoclot-r-eca2302 (data as of 2026-11-18).
- Data sources: [EUDAMED](https://ec.europa.eu/tools/eudamed), [FDA 510(k)](https://open.fda.gov/apis/device/510k/)
- Registry records last synced: 2026-10-25
- Statuses computed as of: 2026-11-18
- JSON: <https://devicerts.com/devices/endoclot-r-eca2302.json>
- Licence: [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/). The deviCERTS layout and text are licensed under CC BY 4.0. Registry data remain under their source terms: U.S. FDA data (openFDA, AccessGUDID) are U.S. public domain; EUDAMED data are subject to the European Commission reuse terms.
- Attribution: DevicErts, https://devicerts.com/devices/endoclot-r-eca2302
- Compiled by deviCERTS (devicerts.com) from public medical device registries (EUDAMED, European Commission; U.S. FDA via openFDA; AccessGUDID, U.S. National Library of Medicine). deviCERTS is not an official register and gives no regulatory advice: the record in the registry itself prevails.
